Technology Targeting the BRCA1 Pseudogene (BRCA1P1) to Inhibit Cancer Progression and Increase Therapy Responses Compositions and methods to target long non-coding RNA (lncRNA) from the BRCA1 pseudogene in breast cancer cells to stimulate the body’s natural immune response, leading to increased cancer cell death…
News Life Sciences Community Convenes at Chicago BioCapital Summit in a Showcase of Local Innovation Hosted by the Chicago Biomedical Consortium (CBC), the inaugural Chicago BioCapital Summit this week brought together industry, academia, and investors in a showcase of the latest innovations in the life...
News Catching Up with NVC Alum CancerIQ and Their New $4.8 Million Series A COVID-19 halted routine cancer screenings. Since the onset of the pandemic, more than 80,000 patients have missed their mammograms, colonoscopies, or other appointments – and they may come out of...
